Global EConsent in Healthcare Market 2023-2030

Description

List of Tables

Global EConsent in Healthcare Market Size, Share & Trends Analysis Report by Enrollment Type (On-site, and Remote Consent), by Deployment Mode (Cloud-based, and Web-based) and by Form Type (General Consent, General Consent with Specific Denial(s), General Denial with Specific Consent(s), and General Denial), Forecast Period (2023-2030)

The global econsent in healthcare market is anticipated to grow at a CAGR of 9.9% during the forecast period (2023-2030). The market's growth is attributed to the increased sponsor control. The addition of tiered license options and extra features in eConsent solutions offers sponsors more control and customization capabilities. This satisfies the desire for customized consent solutions based on the needs of the study. For instance, in April 2021, Signant Health, with the latest released of Smart Signals eConsent, the company has expanded its electronic informed consent products and strengthened its capabilities. Key product functionality enhancements and tiered license options offer sponsors additional control over getting electronic informed consent and reconsent for any study design.

Segmental Outlook

The global econsent in healthcare market is segmented on the enrollment type, deployment mode, and form type. Based on the enrollment type, the market is sub-segmented on-site, and remote consent. Based on the deployment mode, the market is sub-segmented into cloud-based, and web-based. Furthermore, on the basis of form type, the market is sub-segmented into general consent, general consent with specific denial(s), general denial with specific consent(s), general denial. The cloud-based subcategory is expected to capture a significant portion of the market share within the deployment mode segment. The growth can be attributed to the growing use of cloud-based solutions owing to the benefits of minimizing administrative burden and maintaining compliance for sites and study teams. Furthermore, cloud-based eConsent improves the process by incorporating innovative technology and multimedia to provide potential trial participants with an interactive informed consent experience.

The On-Site Sub-Segment is Anticipated to Hold a Considerable Share of the global EConsent in Healthcare Market

Among the application, the content management systems (CMS) sub-segment is expected to hold a considerable share of the global econsent in healthcare market. The segmental growth is attributed to the diverse populations engagement. On-site eConsent can serve a variety of demographics, including those with various degrees of digital literacy or restricted access to technology, enabling fair access to trial material. For instance, in July 2021,CASTOR Launched Scalable Patient Enrollment and eConsent Platform. Clinical trials benefit from decentralization as it makes them more accessible to a wider range of individual. The process additionally encourages transparency and efficiency, reducing the burden on patients by providing a seamless transition throughout the study recruitment and enrollment process.

Regional Outlook

The global econsent in healthcare market is further segmented based on geography including North America (the US, and Canada), Europe (UK, Italy, Spain, Germany, France, and the Rest of Europe), Asia-Pacific (India, China, Japan, South Korea, and Rest of Asia), and the Rest of the World (the Middle East & Africa, and Latin America). Among these, Europe is anticipated to hold a prominent share of the market across the globe, owing to the region's healthcare system is well-developed, in addition to is a significant emphasis on data protection and patient rights, making eConsent solutions an appealing option. The increasing healthcare digitization initiatives, such as widespread adoption of electronic health records and interoperability standards, present a conducive climate for eConsent deployment.

The North America Region is Expected to Grow at a Significant CAGR in the global EConsent in Healthcare Market

Among all regions, the North America regions is anticipated to grow at a considerable CAGR over the forecast period. Regional growth is attributed to the comparative comprehension studies. Comparative research comparing patient comprehension of eConsenting opposed to paper-based Informed Consent Forms (ICFs) has produced positive results. These studies emphasizing improved or comparable knowledge of eConsenting assist to its acceptance. According to the National Institute of Health (gov.) in September 2023, a total of 36 studies meeting the eligibility criteria were included in this review, along with an additional outcomes publication that was retrieved manually. These publications described a total of 35 studies, with 2 studies covered by 2 publications each. The majority of the studies (28/35, 80%) were conducted in North America, with the US accounting for 26 studies and Canada for 2 studies.

Furthermore, in a comprehensive analysis of 26 studies involving a total of 8,778 participants, the aspects of patient comprehension were evaluated in relation to eConsenting. Out of these studies, 20 specifically compared comprehension between eConsenting and paper-based informed consent forms (ICFs), with a total of 6,769 participants contributing comparative data. The findings indicated that eConsenting demonstrated either significantly better understanding, better understanding without statistical significance, or no significant differences in overall comprehension when compared to paper-based ICFs.

Market Players Outlook

The major companies serving the econsent in healthcare market includes Magentus Group Pty Ltd., Medable, Inc., Medrio, Inc., ObvioHealth, and Veeva Systems and others. The market players are considerably contributing to the market growth by the adoption of various strategies including mergers and acquisitions, partnerships, collaborations, funding, and new product launches, to stay competitive in the market. For instance In June 2022, uMotif partnered with ClinOne to provide a seamless experience for patients, caregivers, and sites of proven traditional, DCT, and hybrid trial solutions for eConsent, eCOA / ePRO, behavioral engagement, sensors and wearables, and more.

The Report Covers:

Market value data analysis of 2022 and forecast to 2030.
Annualized market revenues ($ million) for each market segment.
Country-wise analysis of major geographical regions.
Key companies operating in the global econsent in healthcare market. Based on the availability of data, information related to new product launches, and relevant news is also available in the report.
Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.
Analysis of market-entry and market expansion strategies. Competitive strategies by identifying 'who-stands-where' in the market.

Product Code: OMR2027988

1. Report Summary

Current Industry Analysis and Growth Potential Outlook
1.1. Research Methods and Tools
1.2. Market Breakdown
- 1.2.1. By Segments
- 1.2.2. By Region

2. Market Overview and Insights

2.1. Scope of the Report
2.2. Analyst Insight & Current Market Trends
- 2.2.1. Key Findings
- 2.2.2. Recommendations
- 2.2.3. Conclusion

3. Competitive Landscape

3.1. Key Company Analysis
3.2. Citadel Group Ltd.
- 3.2.1. Overview
- 3.2.2. Financial Analysis
- 3.2.3. SWOT Analysis
- 3.2.4. Recent Developments
3.3. Florence Healthcare, Inc.
- 3.3.1. Overview
- 3.3.2. Financial Analysis
- 3.3.3. SWOT Analysis
- 3.3.4. Recent Developments
3.4. Health Catalyst
- 3.4.1. Overview
- 3.4.2. Financial Analysis
- 3.4.3. SWOT Analysis
- 3.4.4. Recent Developments
3.5. Key Strategy Analysis

4. Market Segmentation

4.1. Global EConsent in Healthcare Market by Entrollment Type
- 4.1.1. On-site
- 4.1.2. Remote Consent
4.2. Global EConsent in Healthcare Market by Deployment Mode
- 4.2.1. Cloud-Based
- 4.2.2. Web-Based
4.3. Global EConsent in Healthcare Market by Form Type
- 4.3.1. General Consent
- 4.3.2. General Consent With Specific Denial(S)
- 4.3.3. General Denial With Specific Consent(S)
- 4.3.4. General Denial

5. Regional Analysis

5.1. North America
- 5.1.1. United States
- 5.1.2. Canada
5.2. Europe
- 5.2.1. UK
- 5.2.2. Germany
- 5.2.3. Italy
- 5.2.4. Spain
- 5.2.5. France
- 5.2.6. Rest of Europe
5.3. Asia-Pacific
- 5.3.1. China
- 5.3.2. India
- 5.3.3. Japan
- 5.3.4. South Korea
- 5.3.5. Rest of Asia-Pacific
5.4. Rest of the World

6. Company Profiles

6.1. 5thPort, LLC
6.2. Calysta EMR
6.3. Cloudbyz
6.4. Concentric
6.5. EvidentIQ Group GmbH
6.6. IQVIA
6.7. Magentus Group Pty Ltd.
6.8. Medable, Inc.
6.9. Medrio, Inc.
6.10. ObvioHealth
6.11. Signant Health
6.12. Sitero
6.13. Suvoda LLC,
6.14. Thieme Compliance GmbH
6.15. Veeva Systems